HAEM: Multiple Myeloma Flashcards

1
Q

What are the expansile tumours of MM called?

A

Plasmacytomas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the two types of abundant proteins in myeloma?

A

Bence jones = free light chains

Monoclonal IgA/G a.k.a. paraprotein/M spike

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Compare MM and Waldenstrom’s.

A
W = IgM producing cells
MM = IgG/IgA producing cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the most common premalignant condition?

A

MGUS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

If the patient has IgG/IgA MGUS what will they progress to?

A

Myeloma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

If the patient has IgM MGUS what will they progress to?

A

Lymphoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

In MGUS definition:

a) What is the serum M protein level?
b) BM clonal plasma cell %?

A

a) <30g/L

b) <10%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What must be excluded in MGUS?

A

They must have no LYTIC BONE lesions, no MM-type organ/tissue damage, no other B-CELL proliferative disorder

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What criteria stratifies risk to MM progression in MGUS?

A

Mayo criteria - looks at non-IgG spike, if M-spike >15g/L and at SFLC ratio

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the two main criteria which define smouldering MM?

A

a). M protein >30g/L (or urinary 0.5g/day)
+/- BM plasma cells 10-60%
b) No amyloidosis and no MM defining events

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What criteria stratifies risk to MM progression in smouldering MM?

A

IMWG 2019 (if everything >20 incl SFLC ratio then poor prognosis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

List the stages of progression of myeloma.

A
MGUS - PC <10%, M <30g/L
Smouldering - PC>10%, M >30g/L
Symptomatic MM*
Remitting relapsing MM
Refractory 
Plasma cell leukaemia 
  • > 10% or plasmacytoma + urine/serum paraprotein+ symptoms after this stage
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the most common primary genetic event in MM? What about secondary?

A
1o = Hyperploidy 
2o = copy number abnormalities, hypomethylation, mutations
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the CRAB criteria for MM?

A
CRAB
Calcium >2.75mmol/L
Renal Cr>177 or eGFR <40
Anaemia <100g/L or -20
Bone disease - lytic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the myeloma defining events i.e. numbers/%?

A

a) PC >60%
b) SFLC ratio >100 (invovled:uninvolved)
c) >1 focal bone lesion on MRI (>5mm)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the two main emergencies in MM?

A

Cord compression and hypercalcaemia

17
Q

What are the causes of myeloma kidney disease?

A
Cast nephropathy 
Bence Jones proteins 
Hypercal 
Dehydration 
Other: infection, drugs (loop diuretics, nephrotoxics)
18
Q

How do casts form in MM kidney disease? How does AL amyloidosis form?

A

Light chains and Tamm Horsfall glycoproteins accumulate in proximal tubule forming casts

AL - misfolded free light (LAMBDA in most) chains aggregate in target organs

19
Q

What biologic is the main used in MM kidney disease?

A

Bortezomib

20
Q

Which CD antigen should be tested for in MM?

A

CD138 with immunohistochemistry

21
Q

Name a high risk mutation in MM.

A

del(17q)
t(4;14) IGH/FGFR3
t(14;16) - IGH/MAF

22
Q

Is amount or amyloidogenic potential of free light chains more important for AL amyloid development?

23
Q

Name the light chains most commonly implicated in renal and cardiac AL amyloid.

A

Lambda chain
Renal - IGLV 6-57
Cardiac - IGLV 1-44

24
Q

What are the complications of AL amyloidosis?

A

NephrOtic syndrome –> proteinuria (not BJP)

etc

25
Q

Which AL amyloid complication is the biggest determinant of prognosis?

A

HF is the biggest prognostic determinant - NT-proBNP will be raised, abnormal echo and cardiac MRI

26
Q

Name two alkylators used for MM.

A

Melphalan

Cyclophosphamide

27
Q

Name 2 steroids for MM.

A

Dexa and pred

28
Q

Name 2 immunomod drugs for MM.

A

-omides e.g. lenalidomide (less toxic, more potent), thalidomide

29
Q

…… binding molecules for MM.

A

Cereblon binding molecules

30
Q

Name 2 proteosome inhibitors for MM. Why are they useful?

A

Bortezomib
Carfilzomib
Ixazomib

Plasma cells proteosomes are crucial for removing misfolded proteins so if you remove this fucntion apoptosis of plasma cells will occur due to stress

31
Q

What mAbs can be used in MM? What is their target?

A

Daratumumab - anti CD38 expressed in normal and malignant plasma cells
Isatuximab

32
Q

What is used for maintenance therapy in MM autologous transplanted patients?

A

Lenalidomide

33
Q

What is the main treatment for transplant-ineligible patients?

A

Lenalidomide + dex

or other similar regimens

34
Q

Is MM curable?